These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Advisory for fungal drugs. FDA Consum; 2001; 35(4):4. PubMed ID: 11692887 [No Abstract] [Full Text] [Related]
23. Oral corticosteroids did not prevent AGEP due to terbinafine. Bajaj V; Simpson N Acta Derm Venereol; 2006; 86(5):448-9. PubMed ID: 16955194 [No Abstract] [Full Text] [Related]
24. Generalized pustular eruptions due to terbinafine. Ozturk G; Turk BG; Karaca N; Karaarslan IK; Ertekin B; Ertam I; Kazandi A; Kandiloglu G Cutan Ocul Toxicol; 2012 Mar; 31(1):81-4. PubMed ID: 21888496 [TBL] [Abstract][Full Text] [Related]
25. Acute generalized exanthematous pustulosis induced by terbinafine. Taberner R; Puig L; Gilaberte M; Alomar A Eur J Dermatol; 2003; 13(3):313-4. PubMed ID: 12805000 [TBL] [Abstract][Full Text] [Related]
26. [Liver damage during administration of itraconazole (Trisporal)]. Jacobs AE Ned Tijdschr Geneeskd; 1993 Jan; 137(2):97-8. PubMed ID: 8380628 [No Abstract] [Full Text] [Related]
27. [Amphotericin B associated with severe liver toxicity]. Campo C; Antón E; Morata C; Lacruz J Rev Clin Esp; 1999 Jan; 199(1):49. PubMed ID: 10089782 [No Abstract] [Full Text] [Related]
28. Unintentional rechallenge resulting in a causative relationship between ketoconazole and acute liver injury. Chien RN; Sheen IS; Liaw YF Int J Clin Pract; 2003 Nov; 57(9):829-30. PubMed ID: 14686574 [TBL] [Abstract][Full Text] [Related]
29. Terbinafine: Safety profile and monitoring in treatment of dermatophyte infections. Sun CW; Hsu S Dermatol Ther; 2019 Nov; 32(6):e13111. PubMed ID: 31595639 [No Abstract] [Full Text] [Related]
30. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection. Paredes AH; Lewis JH Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078 [TBL] [Abstract][Full Text] [Related]
31. Reversible agranulocytosis associated with oral terbinafine in a pediatric patient. Aguilar C; Mueller KK J Am Acad Dermatol; 2001 Oct; 45(4):632-4. PubMed ID: 11568763 [TBL] [Abstract][Full Text] [Related]
32. Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil. Cetkovská P; Pizinger K Int J Dermatol; 2006 Mar; 45(3):320-2. PubMed ID: 16533240 [TBL] [Abstract][Full Text] [Related]
33. Oral terbinafine-induced bullous pemphigoid. Aksakal BA; Ozsoy E; Arnavut O; Ali Gürer M Ann Pharmacother; 2003 Nov; 37(11):1625-7. PubMed ID: 14565807 [TBL] [Abstract][Full Text] [Related]
34. Acute generalized exanthematous pustulosis associated with terbinafine: a case report. Turan H; Acer E; Erdem H; Uslu E; Aliagaoglu C Cutan Ocul Toxicol; 2013 Oct; 32(4):325-6. PubMed ID: 23432048 [TBL] [Abstract][Full Text] [Related]
36. Terbinafine and fulminant hepatic failure. Agarwal K; Manas DM; Hudson M N Engl J Med; 1999 Apr; 340(16):1292-3. PubMed ID: 10215503 [No Abstract] [Full Text] [Related]
37. Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine. Lovell MO; Speeg KV; Havranek RD; Sharkey FE Hum Pathol; 2003 Feb; 34(2):187-9. PubMed ID: 12612888 [TBL] [Abstract][Full Text] [Related]
38. Acute generalized exanthematous pustulosis in a child probably induced by terbinafine. Bayata S; Ermertcan AT; Ates M; Temiz P Indian J Dermatol Venereol Leprol; 2015; 81(1):95. PubMed ID: 25566924 [No Abstract] [Full Text] [Related]
39. Spontaneous tolerance to terbinafine-induced lichenoid drug eruption. Teraki Y; Shiohara T Dermatology; 2004; 208(1):81-2. PubMed ID: 14730245 [No Abstract] [Full Text] [Related]